InvestorsHub Logo
Followers 26
Posts 2877
Boards Moderated 0
Alias Born 12/05/2021

Re: HappyLibrarian post# 688073

Tuesday, 04/30/2024 2:48:43 PM

Tuesday, April 30, 2024 2:48:43 PM

Post# of 701402
As I have said here a few times I think NWBO will be bought for a price between $15 billion on the low end
https://www.biopharmadive.com/news/merck-dealmaking-15-billion-keytruda-cliff-davis/706309/

Merck keeps deal focus with Keytruda patent cliff on horizon The company is open to acquisitions of up to $15 billion, company CEO Rob Davis said


and $21 billion on the more realistic higher-end
https://www.gilead.com/news-and-press/press-room/press-releases/2020/9/gilead-sciences-to-acquire-immunomedics

Gilead Sciences, Inc. (Nasdaq: GILD) and Immunomedics (Nasdaq: IMMU) announced today that the companies have entered into a definitive agreement pursuant to which Gilead will acquire Immunomedics for $88.00 per share in cash. The transaction, which values Immunomedics at approximately $21 billion, was unanimously approved by both the Gilead and Immunomedics Boards of Directors and is anticipated to close during the fourth quarter of 2020.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News